Application of maternal plasma DNA analysis for noninvasive prenatal diagnosis of Hb E-β-thalassemia

Translational Research

Volumn 150, Issue 5, 2007, Pages 319-325

  Tungwiwat, Warunee ^a   Fucharoen, Goonnapa ^a   Fucharoen, Supan ^a   Ratanasiri, Thawalwong ^b   Sanchaisuriya, Kanokwan ^a   Sae Ung, Nattaya ^a  

^a KHON KAEN UNIVERSITY   (Thailand)

^b KHON KAEN UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GLOBIN; HEMOGLOBIN E; PLASMID DNA;

ARTICLE; BETA THALASSEMIA; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; DNA DETERMINATION; FEMALE; FETUS; FIRST TRIMESTER PREGNANCY; GENE IDENTIFICATION; GENETIC RISK; HETEROZYGOTE; HUMAN; HUMAN TISSUE; MATERNAL PLASMA; METHODOLOGY; NON INVASIVE MEASUREMENT; POLYMERASE CHAIN REACTION; PREGNANT WOMAN; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SECOND TRIMESTER PREGNANCY;

EID: 35349010228     PISSN: 19315244     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trsl.2007.06.006     Document Type: Article

References (25)

1. Wasi P., Pootrakul S., Pootrakul P., Pravatmuang P., Winichagoon P., and Fucharoen S. Thalassemia in Thailand. Ann NY Acad Sci 344 (1980) 352-363
2. Fucharoen S., and Winichagoon P. Hemoglobinopathies in Southeast Asia. Hemoglobin 11 (1987) 65-88
3. Fucharoen G., Fucharoen S., Jetsrisuparp A., and Fukumaki Y. Molecular basis of HbE-beta-thalassemia and the origin of HbE in northeast Thailand: identification of one novel mutation using amplified DNA from buffy coat specimens. Biochem Biophys Res Commun 170 (1990) 698-704
4. Fucharoen S., Fucharoen G., Sriroongreung W., Laosombat V., Jetsrisuparb A., Prasatkaew S., et al. Molecular basis of β-thalassemia in Thailand: analysis of β-thalassemia mutations using the polymerase chain reaction. Hum Genet 84 (1989) 41-46
5. Fucharoen S., Winichagoon P., Thonglairuam V., Siriboon W., Siritanaratkul N., Kanokpongsakdi S., et al. Prenatal diagnosis of thalassemia and hemoglobinopathies in Thailand: experience of 100 pregnancies. South East Asian J Trop Med Public Health 22 (1991) 16-19
6. Lo Y.M., Corbetta N., Chamberlain P.F., Rai V., Sargent I.L., Redman C.W., et al. Presence of fetal DNA in maternal plasma and serum. Lancet 350 (1997) 485-487
7. Chiu R.W., Lau T.K., Leung T.N., Chow K.C., Chui D.H., and Lo Y.M. Prenatal exclusion of beta thalassemia major by examination of maternal plasma. Lancet 360 (2002) 998-1000
8. Fucharoen G., Tungwiwat W., Ratanasiri T., Sanchaisuriya K., and Fucharoen S. Prenatal detection of fetal hemoglobin E gene from maternal plasma. Prenat Diagn 23 (2003) 393-396
9. Tungwiwat W., Fucharoen G., Ratanasiri T., Sanchaisuriya K., and Fucharoen S. Non-invasive fetal sex determination using a conventional nested PCR analysis of fetal DNA in maternal plasma. Clin Chim Acta 334 (2003) 173-177
10. 0-thalassemia from maternal plasma. Ann NY Acad Sci 1075 (2006) 103-107
11. Lo Y.M., Tein M.S., Lau T.K., Haines C.J., Leung T.N., Poon P.M., et al. Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am J Hum Genet 62 (1998) 768-775
12. Holzgreve W., and Hahn S. Prenatal diagnosis using fetal cells and free fetal DNA in maternal blood. Clin Perinatol 28 (2001) 353-365
13. Honda H., Miharu N., Ohashi Y., Samura O., Kinutani M., Hara T., et al. Fetal gender determination in early pregnancy through qualitative and quantitative analysis of fetal DNA in maternal serum. Hum Genet 110 (2002) 75-79
14. Pertl B., Sekizawa A., Samura O., Orescovic I., Rahaim P.T., and Bianchi D.W. Detection of male and female fetal DNA in maternal plasma by multiplex fluorescent polymerase chain reaction amplification of short tandem repeats. Hum Genet 106 (2000) 45-49
15. Lo Y.M.D., Hjelm M., Fidler C., Sargent I.L., Murphy M.F., Chamberlain P.F., et al. Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma. N Engl J Med 10 (1998) 174-178
16. Amicucci P., Gennarelli M., Novelli G., and Dallapiccola B. Prenatal diagnosis of myotonic dystrophy using fetal DNA obtained from maternal plasma. Clin Chem 46 (2000) 301-302
17. Chiu R.W.K., Lau T.K., Cheung P.T., Gong Z.Q., Leung T.N., and Lo Y.M.D. Noninvasive prenatal exclusion of congenital adrenal hyperplasia by maternal plasma analysis: a feasibility study. Clin Chem 48 (2002) 778-780
18. Chiu R.W.K., Lau T.K., Leung T.N., Chow K.C.K., Chui D.H., and Lo Y.M.D. Prenatal exclusion of β-thalassemia major by examination of maternal plasma. Lancet 360 (2002) 998-1000
19. Ding C., Chiu R.W., Lau T.K., Leung T.N., Chan L.L., Chan A.Y.Y., et al. MS analysis of single nucleotide differences in circulating nucleic acids: application to noninvasive prenatal diagnosis. Proc Natl Acad Sci USA 101 (2004) 10762-10767
20. Li Y., Di Naro E., Vitucci A., Zimmermann B., Holzgreve W., and Hahn S. Detection of paternally inherited fetal point mutations for β-thalassemia using size-fractionated cell-free DNA in maternal plasma. JAMA 293 (2005) 843-849
21. Papasavva T., Kalakoutis G., Kalikas I., Neokli E., Papacharalambous S., Kyrri A., et al. Noninvasive prenatal diagnostic assay for the detection of β-thalassemia. Ann NY Acad Sci 1075 (2006) 148-153
22. Leung T.N., Zhang J., Lau T.K., Hjelm N.M., and Lo Y.M.D. Maternal plasma fetal DNA as a marker for preterm labour. Lancet 352 (1998) 1904-1905
23. Zhong X.Y., Holzgreve W., and Hahn S. Circulating fetal and maternal DNA in pregnancies at risk and those affected by preexclampsia. Ann NY Acad Sci 945 (2001) 138-140
24. Leung T.N., Zhong J., Lau T.K., Chan T.Y., and Lo Y.M.D. Increased maternal plasma fetal DNA concentrations in women who eventually develop preexclampsia. Clin Chem 47 (2001) 137-139
25. Sekizawa A., Farina A., Koide K., Iwasaki M., Honma S., Ichizuka K., et al. β-Globin DNA in maternal plasma as a molecular marker of pre-exclampsia. Prenat Diagn 24 (2004) 697-700